Virtual Opioid Safety Summit
October 26, 2022
4:00 pm to 6:00 pm
Click here to join us through Zoom: https://us02web.zoom.us/j/87242877272?pwd=TEdYeVczQXhxc0g0bTN0YWtkRXhSdz09
Passcode: 102622
Presenters and Topics:
Janneiry Garcia - High Intensity Drug Trafficking Area (HIDTA) & Overdose Response Strategy (ORS)
The Overdose Response Strategy (ORS) a unique collaboration between CDC and the High Intensity Drug Trafficking Areas (HIDTA) program designed to enhance public health and public safety partnerships. The mission of the ORS is to help communities reduce fatal and non-fatal drug overdoses by connecting public health and public safety agencies, sharing information, and supporting evidence-based interventions. With support from the Office of National Drug Control Policy and CDC, this program offers evidence-based intervention strategies that can be implemented at the local, regional, and state level. For example, CDC partners with the National Association of County and City Health Officials to fund ORS pilot projects that enhance public health and public safety collaborations at the local level.
Sheetal Chowdhary, DO - Youth Mental Health & SUD Vulnerabilities and the CRAFFT Screening Tool
There are certain reasons why the youth brain especially is vulnerable to mental conditions and substance use disorder. We all can take simple steps to try to prevent or delay youth mental health deterioration and substance use disorder. Furthermore, if we can identify and target at-risk youth with strategies to minimize mental health disorders and substance use disorder, then we can potentially decrease decades of associated deaths, overdoses, and an exhaustion of community resources. We can risk-stratify youths (12-21 years old) for substance use disorder using the CRAFFT screening tool questionnaire developed by Harvard and Boston Children’s Hospital.
Anna Zepeda Nunez - Drug Overdose Dashboard
Butte and Glenn counties continue to face increasing rates of drug overdose deaths, including those related to opioids, fentanyl and methamphetamine. In this presentation, we will explore recent trends in drug use indicators.